Autophagy-Sirtuin1(SIRT1) Modulated The Endothelial Progenitor Cells (EPCs) Proliferation and Migration Via wnt/β-Catenin/GSK3β Signaling Pathway and Alleviated The Coronary Atherosclerosis (CAS) in Mice

Background and purpose: SIRT1 exerted its link to CAS risk in humans and EPCs presented its reparative role in CAS. In this study, we explored the role of SIRT1 in CAS mice and also its modulation in EPCs.Methods and materials: ApoE-/- mice were fed with high-fat and high-glucose food to establish the CAS animal model with the normally-raised C57BL/6 mice as a healthy control group. 5 ApoE mice were intravenously injected with SIRT1 activator, SRT 2104 and another 5 were injected with inhibitor Nicotinamide in tail. Weight changes were recorded per week. Blood samples were taken from posterior orbital venous plexus and detected by automatic biochemical analyzer for lipid concentrations. Coronary artery tissues were observed. HE staining displayed the pathological condition while Immunohistochemistry (IHC) evaluated the CD34+/VEGFR2+ relative density. In vitro, EPCs were isolated from bone marrow each group and then purified, cultured and verified using immunofluorescence staining (IFS). Thereafter, we examined the modulatory mechanism of SIRT1 in EPCs by RT-PCR, MTT, Western Blot (WB) and colony formation, scratch methods, connecting the wnt/β-catenin/GSK3β signaling pathway.Results:SIRT1 activation negatively regulated the weight and TC, TG and LDL. SIRT1 activator alleviated the lesion area and decreased the CD34+/VEGFR2+ density which was higher in coronary artery tissues in CAS and SIRT1 inhibitor groups. In vitro, SIRT1 activator promoted the bone marrow-derived EPCs proliferation, migration and activated wnt/β-catenin/GSK3β signaling pathway while inhibited the autophagy biomarkers ATG1 and LC3II. Furthermore, inhibition of autophagy led to the upregulation of SIRT1 and increase in cell proliferation, migration and wnt/β-catenin/GSK3β activity. The suppression of the pathway in turn lowered SIRT1 expression in EPCs, attenuated the cell proliferation and migration and promoted autophagy. Conclusion: Taken all the findings together, this research disclosed that SIRT1 activator might perform its protective role in CAS through autophagy inhibition via wnt/β-catenin/GSK3β signaling pathway in EPCs.

[1]  Xinchun Yang,et al.  THRIL mediates endothelial progenitor cells autophagy via AKT pathway and FUS , 2020, Molecular medicine.

[2]  C. Gaudio,et al.  Endothelial progenitor cells predict long-term outcome in patients with coronary artery disease: Ten-year follow-up of the PROCREATION extended study. , 2020, International journal of cardiology.

[3]  Chao-ran Liu,et al.  Low serum level of sirtuin 1 predicts coronary atherosclerosis plaques during computed tomography angiography among an asymptomatic cohort. , 2019, Coronary artery disease.

[4]  R. Rahbarghazi,et al.  Toll-like receptor bioactivity in endothelial progenitor cells , 2019, Cell and Tissue Research.

[5]  Zhiyuan Ma,et al.  PJ34, a PARP1 inhibitor, promotes endothelial repair in a rabbit model of high fat diet-induced atherosclerosis , 2019, Cell cycle.

[6]  H. Chung,et al.  MHY2233 Attenuates Replicative Cellular Senescence in Human Endothelial Progenitor Cells via SIRT1 Signaling , 2019, Oxidative medicine and cellular longevity.

[7]  A. Blum,et al.  Rheumatoid arthritis (RA) and cardiovascular disease. , 2019, Autoimmunity reviews.

[8]  E. Bădilă,et al.  Platelets of Healthy Origins Promote Functional Improvement of Atherosclerotic Endothelial Progenitor Cells , 2019, Front. Pharmacol..

[9]  Shengli Zhao,et al.  Niclosamide-induced Wnt signaling inhibition in colorectal cancer is mediated by autophagy. , 2019, The Biochemical journal.

[10]  Zaher Fanari,et al.  Clinical outcomes of the Dual-Therapy CD34 antibody-covered sirolimus-eluting stent versus standard drug-eluting coronary stents: A meta-analysis. , 2019, Cardiovascular revascularization medicine : including molecular interventions.

[11]  D. Bolignano,et al.  Endothelial Progenitor Cells at the Interface of Chronic Kidney Disease: From Biology to Therapeutic Advancement. , 2018, Current medicinal chemistry.

[12]  M. Dubský,et al.  Endothelial Progenitor Cells Biology in Diabetes Mellitus and Peripheral Arterial Disease and their Therapeutic Potential , 2018, Stem Cell Reviews and Reports.

[13]  R. Rahbarghazi,et al.  Distinct role of autophagy on angiogenesis: highlights on the effect of autophagy in endothelial lineage and progenitor cells , 2018, Stem Cell Research & Therapy.

[14]  G. Guerra,et al.  Circulating endothelial progenitor cells biology and regenerative medicine in pulmonary vascular diseases. , 2018, Current pharmaceutical biotechnology.

[15]  Saurabh Sharma,et al.  Endothelial Progenitor Cells as Molecular Targets in Vascular Senescence and Repair. , 2018, Current stem cell research & therapy.

[16]  M. Santacana,et al.  Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and sensitizes glioblastoma cells to autophagy blockers , 2018, Autophagy.

[17]  Huazi Xu,et al.  Monotropein promotes angiogenesis and inhibits oxidative stress‐induced autophagy in endothelial progenitor cells to accelerate wound healing , 2017, Journal of cellular and molecular medicine.

[18]  Yasuyuki Fujita,et al.  Stem cell‐based peripheral vascular regeneration , 2017, Advanced drug delivery reviews.

[19]  A. Balbarini,et al.  Role of circulating endothelial progenitor cells in the reparative mechanisms of stable ischemic myocardium. , 2017, International journal of cardiology.

[20]  Erica B. Peters Endothelial Progenitor Cells for the Vascularization of Engineered Tissues. , 2017, Tissue engineering. Part B, Reviews.

[21]  H. Figulla,et al.  Endothelial progenitor cells and plaque burden in stented coronary artery segments: an optical coherence tomography study six months after elective PCI , 2017, BMC Cardiovascular Disorders.

[22]  T. Sobrino,et al.  Endothelial Progenitor Cells as a Therapeutic Approach for Intracerebral Hemorrhage. , 2017, Current pharmaceutical design.

[23]  Yan V. Sun,et al.  Myocardial Ischemia and Mobilization of Circulating Progenitor Cells , 2018, Journal of the American Heart Association.

[24]  Kai Hu,et al.  NAMPT regulates senescence, proliferation, and migration of endothelial progenitor cells through the SIRT1 AS lncRNA/miR-22/SIRT1 pathway. , 2016, Biochemical and biophysical research communications.

[25]  Chunbo Wang,et al.  SIRT1/Atg5/autophagy are involved in the antiatherosclerosis effects of ursolic acid , 2016, Molecular and Cellular Biochemistry.

[26]  Hong Wang,et al.  Transcription factor E2-2 inhibits the proliferation of endothelial progenitor cells by suppressing autophagy , 2016, International journal of molecular medicine.

[27]  B. Tesfamariam Endothelial Repair and Regeneration Following Intimal Injury , 2016, Journal of Cardiovascular Translational Research.

[28]  C. Berry,et al.  The relationship between oxidised LDL, endothelial progenitor cells and coronary endothelial function in patients with CHD , 2016, Open Heart.

[29]  Yuqiang Wang,et al.  SIRT1 Protects Against Oxidative Stress‐Induced Endothelial Progenitor Cells Apoptosis by Inhibiting FOXO3a via FOXO3a Ubiquitination and Degradation , 2015, Journal of cellular physiology.

[30]  H. Eldar-Finkelman,et al.  Combined regulation of mTORC1 and lysosomal acidification by GSK-3 suppresses autophagy and contributes to cancer cell growth , 2014, Oncogene.

[31]  Po‐Hsun Huang,et al.  Effects of Cardiovascular Risk Factors on Endothelial Progenitor Cell. , 2014, Acta Cardiologica Sinica.

[32]  K. Poh,et al.  Endothelial progenitor cells in cardiovascular diseases. , 2014, World journal of stem cells.

[33]  C. Gaudio,et al.  Endothelial progenitor cells predict long-term prognosis in patients with stable angina treated with percutaneous coronary intervention: five-year follow-up of the PROCREATION study. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[34]  A. Akhmedov,et al.  Peripheral Blood Monocyte Sirt1 Expression Is Reduced in Patients with Coronary Artery Disease , 2013, PloS one.

[35]  C. Paraskeva,et al.  Autolysosomal β‐catenin degradation regulates Wnt‐autophagy‐p62 crosstalk , 2012, The EMBO journal.

[36]  C. Vrints,et al.  Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: focus on PI3K/AKT/eNOS pathway. , 2010, International journal of cardiology.

[37]  J. Sadoshima,et al.  Sirt1 protects the heart from aging and stress , 2008, Biological chemistry.

[38]  A. Balbarini,et al.  Circulating endothelial progenitor cells characterization, function and relationship with cardiovascular risk factors. , 2007, Current pharmaceutical design.

[39]  G. Nickenig,et al.  Circulating endothelial progenitor cells and cardiovascular outcomes. , 2005, The New England journal of medicine.

[40]  A. Zeiher,et al.  Effects of statins on endothelium and their contribution to neovascularization by mobilization of endothelial progenitor cells. , 2004, Coronary artery disease.

[41]  M. Thompson,et al.  In vitro and in vivo cell-capture strategies using cardiac stent technology - A review. , 2016, Clinical biochemistry.